Does CARFILZOMIB Cause Pulmonary embolism? 288 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 288 reports of Pulmonary embolism have been filed in association with CARFILZOMIB (KYPROLIS). This represents 1.3% of all adverse event reports for CARFILZOMIB.
288
Reports of Pulmonary embolism with CARFILZOMIB
1.3%
of all CARFILZOMIB reports
53
Deaths
168
Hospitalizations
How Dangerous Is Pulmonary embolism From CARFILZOMIB?
Of the 288 reports, 53 (18.4%) resulted in death, 168 (58.3%) required hospitalization, and 50 (17.4%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which CARFILZOMIB Alternatives Have Lower Pulmonary embolism Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL